tradingkey.logo

Artivion Inc

AORT
39.590USD
+0.130+0.33%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.88BMarket Cap
LossP/E TTM

Artivion Inc

39.590
+0.130+0.33%

More Details of Artivion Inc Company

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc Info

Ticker SymbolAORT
Company nameArtivion Inc
IPO dateFeb 12, 1993
CEOMackin (James Patrick)
Number of employees1600
Security typeOrdinary Share
Fiscal year-endFeb 12
Address1655 Roberts Boulevard N W
CityKENNESAW
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30144
Phone17704193355
Websitehttps://artivion.com/
Ticker SymbolAORT
IPO dateFeb 12, 1993
CEOMackin (James Patrick)

Company Executives of Artivion Inc

Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
174.43K
-5000.00%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+6325.00%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+6325.00%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+6325.00%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
125.79K
-5322.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+11125.00%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+6325.00%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+6325.00%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-9420.00%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
33.50K
-7618.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
174.43K
-5000.00%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+6325.00%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+6325.00%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+6325.00%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
125.79K
-5322.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+11125.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Aortic stent grafts
39.59M
34.91%
On X
26.80M
23.63%
Preservation Services
25.72M
22.69%
Bio Glue
18.89M
16.66%
Surgical sealants
18.89M
16.66%
Other
2.39M
2.11%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Aortic stent grafts
39.59M
34.91%
On X
26.80M
23.63%
Preservation Services
25.72M
22.69%
Bio Glue
18.89M
16.66%
Surgical sealants
18.89M
16.66%
Other
2.39M
2.11%

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.85%
The Vanguard Group, Inc.
6.67%
Fidelity Management & Research Company LLC
6.00%
Nomura Investment Management Business Trust
5.24%
Perceptive Advisors LLC
4.26%
Other
65.98%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.85%
The Vanguard Group, Inc.
6.67%
Fidelity Management & Research Company LLC
6.00%
Nomura Investment Management Business Trust
5.24%
Perceptive Advisors LLC
4.26%
Other
65.98%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.94%
Investment Advisor/Hedge Fund
28.30%
Individual Investor
4.29%
Private Equity
4.26%
Hedge Fund
3.33%
Research Firm
1.87%
Pension Fund
1.06%
Bank and Trust
0.34%
Sovereign Wealth Fund
0.04%
Other
3.58%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
410
43.29M
91.25%
+30.07K
2025Q3
417
43.26M
91.49%
+621.40K
2025Q2
388
42.72M
90.85%
+749.95K
2025Q1
378
41.65M
93.88%
+1.56M
2024Q4
361
38.77M
90.20%
+1.92M
2024Q3
344
36.62M
88.99%
+563.89K
2024Q2
325
36.03M
88.04%
+491.62K
2024Q1
322
35.76M
90.55%
-2.03M
2023Q4
321
34.94M
89.27%
+12.56K
2023Q3
319
34.91M
90.03%
-219.54K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.61M
11.85%
+69.64K
+1.26%
Sep 30, 2025
The Vanguard Group, Inc.
3.02M
6.38%
+232.42K
+8.34%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.84M
6%
+642.73K
+29.25%
Sep 30, 2025
Nomura Investment Management Business Trust
2.48M
5.24%
-472.72K
-15.99%
Sep 30, 2025
Perceptive Advisors LLC
2.02M
4.26%
-773.70K
-27.69%
Sep 30, 2025
Morgan Stanley Smith Barney LLC
1.87M
3.94%
-64.00K
-3.31%
Sep 30, 2025
State Street Investment Management (US)
1.54M
3.25%
+25.42K
+1.68%
Sep 30, 2025
Wellington Management Company, LLP
1.50M
3.17%
-212.34K
-12.39%
Sep 30, 2025
Juniper Investment Company, LLC
1.33M
2.82%
-530.76K
-28.47%
Sep 30, 2025
Fred Alger Management, LLC
1.32M
2.78%
-33.71K
-2.50%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AAM Sawgrass US Small Cap Quality Growth ETF
4.14%
Unusual Whales Subversive Democratic Trading ETF
3.4%
ROBO Global Healthcare Technology & Innovation ETF
1.85%
State Street SPDR S&P Health Care Equipment ETF
1.74%
Invesco S&P SmallCap Health Care ETF
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
0.69%
First Trust Small Cap Growth AlphaDEX Fund
0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
0.42%
iShares Micro-Cap ETF
0.33%
View more
AAM Sawgrass US Small Cap Quality Growth ETF
Proportion4.14%
Unusual Whales Subversive Democratic Trading ETF
Proportion3.4%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.85%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.74%
Invesco S&P SmallCap Health Care ETF
Proportion1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.69%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion0.42%
iShares Micro-Cap ETF
Proportion0.33%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI